← Russell 3000 cross-section

RDNT RadNet, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-10, not restated
Healthcare

Scale

Market cap
$6.0bn
Revenue TTM
$2.3bn
Net income TTM
$-21m
Free cash flow
Composite score
33.9
Sector rank
#969

Valuation

P / E
EV / EBITDA
27.0
EV / sales
2.9
FCF yield
Earnings yield vs 10-yr
-5.08pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-0.9%
EBITDA margin
10.7%
ROE
-1.9%
ROIC
4.2%
Revenue growth
18.9%

Insider activity, last 90 days

Net open-market
$-2.98m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Total Revenue Our 11.1% increase in Imaging Center same center revenue compared to the same period last year was driven by higher fees per imaging procedure and increased procedure volumes. The increase in Imaging Center same center total revenue was largely attributable to the procedural volume growth, increased reimbursement from commercial and capitated payors and favorable changes in product mix, as advanced imaging represented a greater proportion of total procedures. Additionally, the increase in same center revenue was the result of net increases in reimbursement from commercial and capitated payors. …RadNet, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-10

Read the full passage →